Search

The pervasiveness of deep space radiation remains a confounding factor for the transit of humans through our solar system. Spacecraft shielding both protects astronauts but also contributes to absorbed dose through galactic cosmic ray interactions that produce secondary particles. The resultant biological effects drop to a minimum for aluminum shielding around 20 g/cm2 but increase with additional shielding. The present work evaluates for the first time, the impact of secondary pions on central nervous system functionality. The fractional pion dose emanating from thicker shielded spacecraft regions could contribute up to 10% of the total absorbed radiation dose. New results from the Paul Scherrer Institute have revealed that low dose exposures to 150 MeV positive and negative pions, akin to a Mars mission, result in significant, long-lasting cognitive impairments. These surprising findings emphasize the need to carefully evaluate shielding configurations to optimize safe exposure limits for astronauts during deep space travel.

The natural radiation environment in Low Earth Orbit (LEO) differs significantly in composition and energy from that found on Earth. The space radiation field consists of high energetic protons and heavier ions from Galactic Cosmic Radiation (GCR), as well as of protons and electrons trapped in the Earth’s radiation belts (Van Allen belts). Protons and some heavier particles ejected in occasional Solar Particle Events (SPEs) might in addition contribute to the radiation exposure in LEO. All sources of radiation are modulated by the solar cycle. During solar maximum conditions SPEs occur more frequently with higher particle intensities. Since the radiation exposure in LEO exceeds exposure limits for radiation workers on Earth, the radiation exposure in space has been recognized as a main health concern for humans in space missions from the beginning of the space age on. Monitoring of the radiation environment is therefore an inevitable task in human spaceflight. Since mission profiles are always different and each spacecraft provides different shielding distributions, modifying the radiation environment measurements needs to be done for each mission. The experiments “Dose Distribution within the ISS (DOSIS)” (2009–2011) and “Dose Distribution within the ISS 3D (DOSIS 3D)” (2012–onwards) onboard the Columbus Laboratory of the International Space Station (ISS) use a detector suite consisting of two silicon detector telescopes (DOSimetry TELescope = DOSTEL) and passive radiation detector packages (PDP) and are designed for the determination of the temporal and spatial variation of the radiation environment. With the DOSTEL instruments’ changes of the radiation composition and the related exposure levels in dependence of the solar cycle, the altitude of the ISS and the influence of attitude changes of the ISS during Space Shuttle dockings inside the Columbus Laboratory have been monitored. The absorbed doses measured at the end of May 2016 reached up to 286 μGy/day with dose equivalent values of 647 μSv/day.

The radiation environment encountered in space differs in nature from that on Earth, consisting mostly of highly energetic ions from protons up to iron, resulting in radiation levels far exceeding the ones present on Earth for occupational radiation workers. Since the beginning of the space era, the radiation exposure during space missions has been monitored with various active and passive radiation instruments. Also onboard the International Space Station (ISS), a number of area monitoring devices provide data related to the spatial and temporal variation of the radiation field in and outside the ISS. The aim of the DOSIS (2009–2011) and the DOSIS 3D (2012–ongoing) experiments was and is to measure the radiation environment within the European Columbus Laboratory of the ISS. These measurements are, on the one hand, performed with passive radiation detectors mounted at 11 locations within Columbus for the determination of the spatial distribution of the radiation field parameters and, on the other, with two active radiation detectors mounted at a fixed position inside Columbus for the determination of the temporal variation of the radiation field parameters. Data measured with passive radiation detectors showed that the absorbed dose values inside the Columbus Laboratory follow a pattern, based on the local shielding configuration of the radiation detectors, with minimum dose values observed in the year 2010 of 195–270 μGy/day and maximum values observed in the year 2012 with values ranging from 260 to 360 μGy/day. The absorbed dose is modulated by (a) the variation in solar activity and (b) the changes in ISS altitude.

The response of Al2O3:C optically stimulated luminescence detectors (OSLDs) was investigated in a 250 MeV pencil proton beam. The OSLD response was mapped for a wide range of average dose rates up to 9000 Gy s−1, corresponding to a ∼150 kGy s−1 instantaneous dose rate in each pulse. Two setups for ultra-high dose rate (FLASH) experiments are presented, which enable OSLDs or biological samples to be irradiated in either water-filled vials or cylinders. The OSLDs were found to be dose rate independent for all dose rates, with an average deviation <1% relative to the nominal dose for average dose rates of (1–1000) Gy s−1 when irradiated in the two setups. A third setup for irradiations in a 9000 Gy s−1 pencil beam is presented, where OSLDs are distributed in a 3 × 4 grid. Calculations of the signal averaging of the beam over the OSLDs were in agreement with the measured response at 9000 Gy s−1. Furthermore, a new method was presented to extract the beam spot size of narrow pencil beams, which is in agreement within a standard deviation with results derived from radiochromic films. The Al2O3:C OSLDs were found applicable to support radiobiological experiments in proton beams at ultra-high dose rates. [ABSTRACT FROM AUTHOR]

Thermoluminescent dosimeters (TLD) and optically stimulated luminescent dosimeters (OSLD) are practical, accurate, and precise tools for point dosimetry in medical physics applications. The charges of Task Group 191 were to detail the methodologies for practical and optimal luminescence dosimetry in a clinical setting. This includes: (a) to review the variety of TLD/OSLD materials available, including features and limitations of each; (b) to outline the optimal steps to achieve accurate and precise dosimetry with luminescent detectors and to evaluate the uncertainty induced when less rigorous procedures are used; (c) to develop consensus guidelines on the optimal use of luminescent dosimeters for clinical practice; and (d) to develop guidelines for special medically relevant uses of TLDs/OSLDs such as mixed photon/neutron field dosimetry, particle beam dosimetry, and skin dosimetry. While this report provides general guidelines for TLD and OSLD processes, the report provides specific details for TLD‐100 and nanoDotTM dosimeters because of their prevalence in clinical practice. [ABSTRACT FROM AUTHOR]